Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Iran, Peace Talks and Prophecy: Trump Says Meeting With Supreme Leader May Be Ahead

Trump Signals Possible Meeting With Iran’s Supreme Leader Amid…
Read more
Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Crisis, Control, and Global Governance: The Road to the Antichrist System

The Globalist Endgame: Understanding the Push Toward World Government For…
Read more
Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

From Globalism to the Antichrist: The Hidden Agenda Revealed

The Rise of Globalism and the Prophetic Push Toward a One-World…
Read more